Results for tag: "Primordial Dwarfism Drug"

Primordial Dwarfism Drug is a type of Endocrine and Metabolic Disorders Drugs used to treat primordial dwarfism, a rare genetic disorder characterized by extreme short stature. These drugs are used to improve growth and development in children with primordial dwarfism, as well as to reduce the risk of complications associated with the disorder. Commonly prescribed drugs include growth hormone, insulin-like growth factor, and anabolic steroids. These drugs are typically administered through injections or oral medications. The Primordial Dwarfism Drug market is a relatively small but growing market, with a focus on providing treatments for this rare disorder. Companies in the market include Novo Nordisk, Pfizer, and Eli Lilly. Show Less Read more